Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection

Clinical trial NCT03147859 · UNKNOWN

Trial details

NCT number: NCT03147859
Sponsor: Ottawa Hospital Research Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-infection/AIDS

Start date: 2017-11-01
Primary completion: 2023-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.